Frontiers in Physiology · Nov 16, 2026

Concordant Elevation of FIB-4 and Liver Stiffness Identifies a Carotid Plaque-Enriched Phenotype in Adults Undergoing Health Examination

By Meijin Zhang, Yanyi Yang, Qingqing Li et al.

Background: Fibrosis-4 index (FIB-4) is recommended as a first-line liver fibrosis screen, whereas liver stiffness measurement (LSM) is used for second-line assessment. Their discordance is common, but the vascular meaning of concordant versus discordant results remains unresolved. We examined whether concordant elevation of FIB-4 and LSM identifies a distinct carotid plaque phenotype and whether this dual-axis information improves individual-level classification. Methods: This retrospective cross-sectional study included adults undergoing health examination, liver elastography, and carotid ultrasonography at the Second Xiangya Hospital during 2022-2025. Elevated FIB-4 was defined using age-adjusted thresholds (≥1.3 at age <65 years and ≥2.0 at age ≥65 years), and elevated LSM as ≥8 kPa. Four concordance phenotypes were compared as the primary analytical framework. Multivariable regression, a formal threshold-defined interaction contrast, exploratory continuous-scale interaction analysis, sensitivity analyses, repeated cross-validation, temporal validation, calibration assessment, decision-curve analysis, and explainable machine learning were performed. Results: Among 8,869 participants with FIB-4, LSM, and plaque data, 5,752 had both measures low, 2,249 had isolated FIB-4 elevation, 577 had isolated LSM elevation, and 291 had both elevated. Strict carotid plaque prevalence was 26.0%, 40.0%, 29.8%, and 52.9%, respectively. After comprehensive adjustment, neither isolated FIB-4 elevation (OR 0.97, 95% CI 0.86-1.10) nor isolated LSM elevation (OR 0.98, 95% CI 0.78-1.22) was associated with plaque, whereas concordant elevation remained associated (OR 1.64, 95% CI 1.25-2.14; P<0.001). However, adding FIB-4, LSM, or their interaction to clinical-component models did not improve repeated-cross-validation AUROC, calibration, Brier score, or net benefit. Conclusions: Concordant elevation of FIB-4 and LSM identifies a carotid plaque-enriched phenotype that is not captured by either isolated abnormality. This pattern should be interpreted as group-level risk enrichment rather than confirmation of liver fibrosis or evidence of continuous biological synergy between the two measurements.

The paperJournal siteBiomarkers

AgingResearch.News